GRg3 enhances the radiosensitivity of esophageal (Li et al., 2021b) and colorectal cancers (Liu T et al., 2018) by downregulating the VEGF, thereby reducing tumor size, inhibiting tumor growth, and prolonging survival. Here, VEGFA is linked to neoplasm.